P. Chakraborty and K. Chakraborty, “Anti-fibrotic agents could be the game-changer for post-COVID-19 pulmonary fibrosis treatment”, European Journal of Biological Research, vol. 12, no. 1, pp. 1-10, Jan. 2022.